Stocktoria
Sarepta Therapeutics, Inc. SRPT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1997-06-04
Sarepta Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 10,324,404 | $1.6B |
| AQR CAPITAL MANAGEMENT LLC | 6,433,112 | $138.6M |
| TWO SIGMA INVESTMENTS, LP | 4,593,195 | $99.9M |
| CITADEL ADVISORS LLC | 2,281,469 | $49.6M |
| RENAISSANCE TECHNOLOGIES LLC | 1,665,078 | $36.2M |
| MILLENNIUM MANAGEMENT LLC | 1,221,682 | $26.6M |
| D. E. Shaw & Co., Inc. | 601,786 | $13.1M |
| Bridgewater Associates, LP | 134,277 | $2.9M |
Source: SEC EDGAR filings · CIK 0000873303 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.